- Home
- SPRY vs NBXG Comparison
SPRY vs NBXG Comparison
Compare SPRY & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- NBXG
- Stock Information
- Founded
- SPRY 2015
- NBXG 2021
- Country
- SPRY United States
- NBXG United States
- Employees
- SPRY N/A
- NBXG N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- NBXG Trusts Except Educational Religious and Charitable
- Sector
- SPRY Health Care
- NBXG Finance
- Exchange
- SPRY Nasdaq
- NBXG Nasdaq
- Market Cap
- SPRY 1.1B
- NBXG 1.1B
- IPO Year
- SPRY N/A
- NBXG N/A
- Fundamental
- Price
- SPRY $11.24
- NBXG $13.46
- Analyst Decision
- SPRY Strong Buy
- NBXG
- Analyst Count
- SPRY 4
- NBXG 0
- Target Price
- SPRY $26.00
- NBXG N/A
- AVG Volume (30 Days)
- SPRY 1.2M
- NBXG 243.7K
- Earning Date
- SPRY 03-20-2025
- NBXG 01-01-0001
- Dividend Yield
- SPRY N/A
- NBXG 10.25%
- EPS Growth
- SPRY N/A
- NBXG N/A
- EPS
- SPRY N/A
- NBXG N/A
- Revenue
- SPRY $2,568,000.00
- NBXG N/A
- Revenue This Year
- SPRY $68,783.34
- NBXG N/A
- Revenue Next Year
- SPRY $503.87
- NBXG N/A
- P/E Ratio
- SPRY N/A
- NBXG N/A
- Revenue Growth
- SPRY 8460.00
- NBXG N/A
- 52 Week Low
- SPRY $7.55
- NBXG $9.31
- 52 Week High
- SPRY $18.51
- NBXG $12.23
- Technical
- Relative Strength Index (RSI)
- SPRY 37.72
- NBXG 48.83
- Support Level
- SPRY $11.58
- NBXG $13.51
- Resistance Level
- SPRY $12.43
- NBXG $13.86
- Average True Range (ATR)
- SPRY 0.72
- NBXG 0.16
- MACD
- SPRY -0.14
- NBXG -0.02
- Stochastic Oscillator
- SPRY 0.53
- NBXG 47.99
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".